Stock Analiz

SYK vs RMD stock comparison

Stryker vs. Resmed · data as of November 13, 2026

Stryker (SYK) has a market value of about $117.9B, Resmed (RMD) about $33.7B. Over their latest twelve months Stryker had revenue of $26.3B and Resmed $5.7B.

On our five checks Resmed scores higher: 4.2 out of 5 (excellent) against 2.8 (average).

By area, the stronger company is Resmed on value; Resmed on track record; Resmed on financial health.

Resmed is cheaper on earnings (P/E 21.8 vs. 33.0).

Stryker leads on 6 of the compared lines and Resmed on 17.

Side by side

SYKRMD
Size and price
Market cap$117.9B$33.7B
Share price$309.64$239.53
Score
Overall score (of 5)2.84.2
Value03
Future growth44
Track record35
Financial health35
Shareholder returns44
Valuation
P/E (TTM)33.021.8
Forward P/E18.918.9
Price / free cash flow25.820.9
Price / sales4.55.9
EV / EBITDA18.515.9
PEG2.220.83
DCF value vs. price−38%−28%
Business
Revenue$26.3B$5.7B
Net income$3.6B$1.6B
Free cash flow$4.6B$1.6B
Net margin13.8%27.8%
Gross margin (5-yr avg.)63.7%57.9%
ROIC (5-yr avg.)9.0%18.9%
Growth
Revenue growth (1 yr)11.2%9.8%
Revenue growth (5 yrs, per year)11.8%12.1%
EPS growth (5 yrs, per year)14.9%26.3%
Balance sheet and payouts
Net cash (cash minus debt)-$12.2B$400M
Dividend yield1.14%1.10%
Shareholder yield1.1%3.2%
Analysts
Upside to average target+10%+10%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: SYK TTM to September 30, 2026, RMD TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Stryker or Resmed?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Resmed scores 4.2 out of 5 and Stryker 2.8; the table shows where each one is stronger.

Is Stryker cheaper than Resmed?

On trailing earnings, Resmed trades at a P/E of 21.8 and Stryker at 33.0, so Resmed is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Stryker or Resmed?

Over five years Resmed grew revenue about 12.1% a year and Stryker about 11.8% a year.

Which pays a higher dividend?

Stryker yields 1.14% and Resmed 1.10%.

Full Stryker analysis → Full Resmed analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.